Case Study

Achieving Recruitment Objectives In Dermatology Trial: Reducing Timeline And Cost

Patient Recruitment

IQVIA Biotech was selected to help a U.S. biopharmaceutical company examine the safety and efficacy of its investigational therapy for the treatment of moderate-to-severe hidradenitis suppurativa (HS), a chronic skin condition that causes small, but painful lumps under the skin. This case study will highlight IQVIA Biotech’s unique strategies for site selection and centralized recruitment approach to drive enrollment. For more information, download the available case study.

VIEW THE CASE STUDY!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Hydrocarbon Online? Subscribe today.

Subscribe to Hydrocarbon Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Hydrocarbon Online